----------------------------
OMB APPROVAL
----------------------------
OMB Number 3235-0145
Expire August 31, 1999
Estimated average burden
hours per response.....14.90
----------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 8 )*
Merit Medical Systems, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, No Par Value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
589889-10-4
-----------
(CUSIP Number)
December 31, 1998
------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[x] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB control number.
Page 1 of 5 Pages
SEC 1745 (2-95)
<PAGE>
CUSIP No. 589889-10-4
-----------
- --------------------------------------------------------------------------------
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Fred P. Lampropoulos
-----------------------------------------------------------------------
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
----
(b)
----
- --------------------------------------------------------------------------------
3. SEC Use Only ----------------------------------------------------------
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization United States
----------------------------
- --------------------------------------------------------------------------------
Number of 5. Sole Voting Power 699,593
Shares Bene- --------------------------
ficially
Owned by Each 6. Shared Voting Power None
Reporting -------------------------
Person With:
7. Sole Dispositive Power 699,593
---------------------
8. Shared Dispositive Power None
--------------------
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 699,593
-----------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions) [ ]
11. Percent of Class Represented by Amount in Row (9) 9.2 %
---------------------
12. Type of Reporting Person (See Instructions) IN
----------------------------
Page 2 of 5 Pages
SEC 1745 (2-95)
<PAGE>
CUSIP No. 589889-10-4
Item 1.
(a) Name of Issuer: Merit Medical Systems, Inc. (the "Company")
(b) Address of Issuer's Principal Executive Offices: 1600 West Merit
Parkway, South Jordan, Utah 84095
Item 2.
(a) Name of Person Filing: Fred P. Lampropoulos (the "Reporting
Person")
(b) Address of Principal Business Office, if none, Residence: 1600 West
Merit Parkway, South Jordan, Utah 84095
(c) Citizenship: United States
(d) Title of Class of Securities: Common Stock, No Par Value (the
"Common Stock")
(e) CUSIP Number: 589889-10-4
Item 3.
This statement is not filed pursuant to Sections 240.13d-1(b) or
240.13d-2(b) or (c).
Item 4. Ownership
(a) Amount Beneficially Owned: As of December 31, 1998, the Reporting
Person was the beneficial owner of 699,593 shares of the Common
Stock, which included 12,309 shares owned by the Reporting Person
pursuant to the Issuer's 401(k) Plan, based upon the most recent
plan statement timely distributed, and 171,500 shares that the
Reporting Person had the right to acquire pursuant to currently
exercisable options.
(b) Percent of Class: 9.2%
(c) Number of shares as to which the Reporting Person has:
(i) sole power to vote or to direct the vote: 699,593
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition of:
699,593
(iv) shared power to dispose or to direct the disposition of:
None
Item 5. Ownership of Five Percent or Less of a Class
This statement is not being filed to report the fact that as of the
date hereof the Reporting Person has ceased to be the beneficial
owner of more than five percent of the class of securities.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
Not applicable.
Page 3 of 5 Pages
SEC 1745 (2-95)
<PAGE>
Item 8. Identification and Classification of Members of the Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
Not applicable.
Page 4 of 5 Pages
SEC 1745 (2-95)
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 11, 1999
-------------------------
Date
/s/ FRED P. LAMPROPOULOS
-------------------------
Signature
Fred P. Lampropoulos
-------------------------
Name/Title
Page 5 of 5 Pages
SEC 1745 (2-95)
